FDA warning letters
A warning letter is FDA's formal notice that a company broke the law, usually found during an inspection. The company has 15 working days to reply. Letters that go unanswered lead to seizures, import bans or court orders.
44 letters match. Newest first.
-
DrugsNexus Health Solutions LLC dba Harper Meds
FDA warned telehealth seller Harper Meds that its website misbrands compounded semaglutide and tirzepatide with false and misleading claims.
Low -
DrugsTrinity HealthCare Supply, LLC dba altRx
FDA warns altRx over misleading website claims for compounded semaglutide and tirzepatide, including 'clinically proven' and wrong compounder label.
Low -
DrugsVivioMD Group LLC dba VivioMD
FDA warned VivioMD that its website misbrands compounded semaglutide and tirzepatide by implying VivioMD is the compounder.
Low -
DrugsNexlife Inc. dba Nexlife
FDA warned Nexlife that its website labels for compounded semaglutide and tirzepatide falsely suggest Nexlife is the compounder.
Low -
DrugsEzra Holdco LLC dba Ezra
FDA says Ezra's website misbrands compounded semaglutide and tirzepatide by labeling them as Ezra-made when they are not.
Low -
DrugsFITISH
FDA warned FITISH over misleading website claims for compounded semaglutide and tirzepatide, including labels suggesting it is the compounder.
Low -
DrugsRoen Health, Inc. dba RoenRx
FDA warned RoenRx that its website misbrands compounded semaglutide with misleading approval claims and a company label implying it makes the drug.
Medium -
DrugsJoi and Blokes dba Joi + Blokes
FDA warned telehealth seller Joi + Blokes that its website misbrands compounded semaglutide and tirzepatide with false, misleading claims.
Medium -
DrugsClover Meds LLC dba Clover Meds
Clover Meds, a telehealth seller, misbranded compounded semaglutide and tirzepatide with false website claims that it makes the drugs and uses 'FDA-licensed' facilities.
Medium -
DrugsPolleyMed, LLC
FDA says PolleyMed's SaniiSwab nasal swab is an unapproved, misbranded drug sold online with infection-prevention claims and a false FDA approval claim.
High risk -
DrugsWeightless Medical LLC dba WeightCare
FDA warned telehealth seller WeightCare that its website falsely presents it as the compounder of semaglutide and tirzepatide drugs.
Low -
DrugsViv Health, Inc. dba VIV RX
FDA warned telehealth company VIV RX that its website falsely suggests it compounds semaglutide and tirzepatide, making the drugs misbranded.
Medium -
DrugsGood Girl LLC dba GoodGirlRX
FDA warns telehealth seller GoodGirlRX that its website misbrands compounded semaglutide and tirzepatide, claiming FDA approval and implying it is the compounder.
Medium -
DrugsIvim Services LLC dba Ivim
FDA says Ivim's telehealth website mislabels compounded semaglutide and tirzepatide as Ivim-made when it is not the compounder.
Low -
DrugsJoin Josie
FDA says Join Josie's website misbranded compounded semaglutide and tirzepatide by falsely implying FDA approval and naming Join Josie as compounder.
Low -
DrugsKin Meds
FDA warned Kin Meds over false claims for compounded semaglutide and tirzepatide, including implying it is the compounder and that products are approved.
Low -
DrugsLevity Inc. dba Levity
FDA warned Levity over misleading website claims for compounded semaglutide and liraglutide, including implying Levity made the drugs and that they were FDA-approved.
Low -
DrugsBetter Health Labs, Inc. dba Measured
FDA warned telehealth seller Measured its website misbranded compounded semaglutide and tirzepatide by implying it made them and that they were FDA-approved.
Medium -
DrugsDripgym Mobile Parent, LLC dba Amp Health
FDA warned Amp Health that its website misbranded compounded semaglutide and tirzepatide with false maker and approval-implying claims.
Low -
DrugsBelle Health LLC dba Belle
FDA warned Belle Health that its website falsely suggests Belle compounds semaglutide and tirzepatide, making the drugs misbranded.
Low -
DrugsAspen Aesthetics dba Fifty 410
FDA warns Fifty 410 over misleading website claims for compounded semaglutide and tirzepatide, including implied compounding and 'clinically proven' claims.
Low -
DrugsGenesis Health International Inc. dba Genesis
FDA warns Genesis over misleading website claims for compounded semaglutide and tirzepatide.
Low -
DrugsHealthy Living Clinic
FDA warned Healthy Living Clinic that its website misbrands compounded semaglutide by comparing it to Wegovy, Ozempic, and Rybelsus.
Low -
DrugsLovely Meds, Inc. dba Lovely Meds
FDA cited Lovely Meds for misleading website claims that compounded semaglutide and tirzepatide are the same as FDA-approved drugs.
Low -
DrugsHello Cake, Inc. dba Hello Cake
FDA warns Hello Cake, an online telehealth seller, that its website misbrands compounded sildenafil and tadalafil ED drugs as equivalent to Viagra and Cialis.
Medium -
DrugsBioverse, Inc. dba Bioverse
FDA warned Bioverse that its website made false or misleading claims for compounded semaglutide and tirzepatide drugs.
Low -
DrugsFancy Meds, LLC dba Fancy Meds
FDA warns Fancy Meds that its compounded semaglutide and tirzepatide website claims are false or misleading.
Low -
DevicesSeniorLife Technologies, Inc.
FDA warns SeniorLife Technologies that its SeniorLife.AI app is unapproved and misbranded, with quality-system and reporting failures.
High risk -
BiologicsXO Biologix, LLC
XO Biologix markets MaviX, an amniotic-fluid product, as an unapproved new drug and unlicensed biologic.
High risk -
DrugsEnviroServe Chemicals & Cleaners Ltd.
EnviroServe's SOPURE hand sanitizer had manufacturing-quality violations and was sold as an unapproved, misleadingly labeled drug.
High risk -
DrugsAqualex Co., Ltd.
Aqualex, a Korean contract manufacturer, was cited for manufacturing failures and an unapproved OTC sunscreen with misleading labeling.
High risk -
DevicesVitang Technology LLC
Vitang Technology sold dental aligners designed with uncleared software without a new 510(k) and with quality system failures.
High risk -
DrugsVarigard, LLC
Varigard sold hand sanitizers with unapproved COVID-19 claims as unapproved new drugs, FDA says.
High risk -
DevicesDatabazaar.com
Databazaar.com sells KN95 masks claiming COVID-19 protection without FDA approval or clearance.
High risk -
DevicesPairon Solutions LLC
Pairon Solutions sold KN95, surgical, and 3-ply face masks without FDA clearance and with misleading FDA certification claims.
Medium -
DrugsSecret of the Islands
FDA warned Secret of the Islands that its salt scrub products are unapproved and misbranded drugs because of COVID-19 claims.
High risk -
DevicesCaptain's Cloth LLC
FDA warned Captain's Cloth that it sold unapproved KN95 face masks online with misleading FDA-logo claims.
Medium -
DevicesWorld Packaging Solutions, LLC
FDA warned World Packaging Solutions over selling unapproved Purvigor KN95 masks with misleading FDA approval claims.
High risk -
DevicesNature’s Distributing; Club Clean Inc/BuyMedicalMasksNow.com
FDA warned Nature’s Distributing/Club Clean for selling unapproved KN95 and 3-ply masks with false FDA certification claims for COVID-19.
High risk -
DevicesBMHshop
BMHshop sold unapproved KN95 and surgical masks with COVID-19 claims and misleading FDA registration certificates, FDA warned.
High risk -
Devicesmaskshell.com
FDA warned maskshell.com over selling unapproved, misbranded KN95, surgical, and children’s masks with misleading FDA-logo certifications.
High risk -
DevicesInnova Medical Group, Inc.
Innova Medical Group distributed unapproved COVID-19 antigen tests and had quality-system and labeling violations, FDA says.
High risk -
DevicesIkcon Investments, Inc dba Ikcon Medical
FDA warned Ikcon Medical that it sold unapproved COVID-19 antibody and antigen tests online and made misleading 'FDA registered' claims.
High risk -
FoodSafaLab, Inc.
FDA and FTC warned SafaLab over unapproved, misbranded COVID-19 drug claims for The Prevention 12 Pak supplements.
High risk